Exposure | Outcome (UKB database) | Method | Statistics Q | P value |
Allergic rhinitis | asthma | MR Egger | 157.899 |  < 0.001 |
IVW | 158.858 |  < 0.001 | ||
Allergic rhinitis | COPD | MR Egger | 79.186 | 0.263 |
IVW | 81.003 | 0.244 | ||
Allergic rhinitis | ILD | MR Egger | 219.557 |  < 0.001 |
IVW | 219.607 |  < 0.001 | ||
Nasal polyps | COPD | MR Egger | 12.525 | 0.639 |
IVW | 12.574 | 0.704 | ||
Nasal polyps | bronchiectasis | MR Egger | 9.943 | 0.445 |
IVW | 13.439 | 0.266 | ||
Exposure | Outcome (FinnGen database) | Method | Statistics Q | P value |
Allergic rhinitis | asthma | MR Egger | 221.575 |  < 0.001 |
IVW | 225.498 |  < 0.001 | ||
Allergic rhinitis | COPD | MR Egger | 194.327 |  < 0.001 |
IVW | 196.872 |  < 0.001 | ||
Allergic rhinitis | ILD | MR Egger | 155.747 | 0.007 |
IVW | 156.728 | 0.007 | ||
Nasal polyps | COPD | MR Egger | 27.622 | 0.050 |
IVW | 29.956 | 0.038 | ||
Nasal polyps | bronchiectasis | MR Egger | 16.426 | 0.563 |
IVW | 17.211 | 0.576 |